| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.5 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.5 |